acebutolol has been researched along with Aortic Stenosis, Subvalvular in 1 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Aortic Stenosis, Subvalvular: A pathological constriction occurring in the region below the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Ascia, C | 1 |
| Rengo, F | 1 |
| Petrillo, C | 1 |
| Giunta, A | 1 |
| De Caprio, L | 1 |
| Romano, M | 1 |
| Condorelli, M | 1 |
1 other study available for acebutolol and Aortic Stenosis, Subvalvular
| Article | Year |
|---|---|
[Comparison of the protective action of 2 beta-blocking agents (acebutolol and propranolol) on myocardial hypertrophy experimentally induced in the rat by means of aortic stenosis].
Topics: Acebutolol; Animals; Aortic Stenosis, Subvalvular; Cardiomegaly; Cardiomyopathy, Hypertrophic; Propr | 1981 |